PP

Piyush Pramod Bagde

Active Director Director DIN 10907971
DIN 10907971 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Piyush Pramod Bagde

Data last updated:

Piyush Pramod Bagde is a Director at Gentiana Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10907971
Primary Designation Director
Industry Pharma
First Appointment 15 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jan 20252025Active

Board colleagues of Piyush Pramod Bagde

NameDINCompanyDesignation
Saurabh Pramod Bagde10907972Gentiana Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gentiana Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Piyush Pramod Bagde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Piyush Pramod Bagde

Piyush Pramod Bagde currently holds 1 directorship: Gentiana Pharmaceuticals Private Limited (Director, since 15 Jan 2025).

Piyush Pramod Bagde was first appointed on 15 Jan 2025 as Director at Gentiana Pharmaceuticals Private Limited.

The current boards of Piyush Pramod Bagde's companies include Saurabh Pramod Bagde (Gentiana Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available